Janus kinase-3 (Jak3) is a nonreceptor tyrosine kinase functionally coupled to cytokine receptors which share a "common" y chain (yc). Mutations in "/e and Jak3 genes have been identified in X-linked and autosomal severe combined immune deficiency (SCID), respectively. Jak3 is expressed and activated in myelomonocytic cells. The present study was designed to define the structural alteration responsible for lack of Jak3 in a patient with autosomal SClD and to characterize monocyte function in the absence of this signal transduction element, as well as to establish the whole exon-intron structure. Polymerase chain reaction analysis, performed with primers designed on exon sequences, identified 20 exons spanning approximately 15 kb. These primers, or others designed on the flanking sequences provided in the present report, can be used to amplify the whole gene, allowing the definition of the molecular defects in all cases, including prenatal diagnosis, in which transcript analysis is ANUS FAMILY kinases are nonreceptor tyrosine kinases J that have emerged as key elements in the signal transduction pathway of cytokine receptors.'-3 Janus kinase 3 (Jak3) is a member of this family with a restricted pattern of expression in vitro and in Jak3 is functionally coupled with cytokine receptors (interleukin-2 [IL-21, IL-4, IL-7, IL-9, and IL-15) that share a common y (yc) chain (hereafter referred as yc receptor^).^ Severe combined immune deficiency (SCID) is a heterogeneous group of hereditary diseases. Mutations in the yc chain have been identified in X-linked SCID, characterized by lack of T cells and presence of B cell^.^,^ Mutations of Jak3 have recently been identified in autosomal SCID with normal yc
These patients show lack of T and natural killer (NK) cells.
Jak3 is expressed in myelomonocytic cells, including fresh human monocytes.6." Monocyte expression of Jak3 is augmented by bacterial lipopolysaccharide (LPS) and interferony (IFN-y)." Cytokines binding yc chain receptors, IL-2 and IL-4 in particular, have profound effects on the function of cells of the monocyte-macrophage series.'2-20 Jak3 is tyrosine-phosphorylated and activated in myelomonocytic cells exposed to yc chain cytokines, indicating functional coupling.6,' I The present study was designed to define the molecular basis for lack of Jak3 expression in a patient with autosomal SCID and to characterize the function of monocytes in the absence of Jak3. By segmental polymerase chain reaction (PCR) amplification with primers designed on exon sequences, we found that the Jak3 gene is organized in 20 exons spanning approximately 15 kb. Lack of Jak3 in the autosomal SCID patient under study was associated with a point mutation at a splice donor site. In the absence of detectable Jak3, monocytes showed normal responses to IL-2 and IL-4, which bind yc receptors, as well as to LPS and IFNy. in terms of augmentation and/or inhibition of function. Thus, Jak3 is dispensable for monocyte differentiation and function.
not possible. On this basis, the deletion transcript found at the homozygous state in patient CM, with both his consanguineous parents being heterozygous for the deletion, was associated with mutation (T to C) of a splice donor site of intron 16 that was also detected in his mother's DNA. Monocytes from JaW-SClD showed normal cytokine production in response to interleukin-4 (IL-4) (release of IL-1 receptor antagonist) and IL-2 (release of tumor necrosis factor-a and IL-8). Lipopolysaccharide-induced cytokine production was also normal and was blocked by IL-4 in Jak3-SClD monocytes. Interferon-y induced augmented expression of major histocompatibility class II in Jak3-SClD monocytes. These data indicate that Jak3, expressed and activated in myelomonocytic cells, is dispensable for monocyte differentiation and responsiveness to cytokines that interact with yc receptors as well as to other regulatory signals.
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MATERIALS AND METHODS
The clinical, immunological, and molecular characteristics of patient CM were recently reported.' Briefly, the baby was affected by autosomal SCID with a B' T-phenotype. At the time of peripheral blood mononuclear cell (PBMC) harvesting for this series of experiments, performed before successful bone marrow transplantation (BMT), CM had a total white blood cell (WBC) count of 3.6 X 109/L, with 32% lymphocytes, 57.7% neutrophils, 1.9% eosinophils, and 8.6% monocytes. Lymphocyte subsets (%) were as follows: CD3 = 0.7; CD4 = 0.8; CD8 = 0.1; CD19 = 92; CD16 = 0.3. Controls tested in each assay included normal laboratory donors, the mother, a baby of similar age with spherocytosis, and one with Omenn syndrome.
Primers were designed for the amplification of the whole Jak3 gene, based on the sequence reported by Kawamura et al? Genomic DNA was extracted with the phenoYchlomform procedure from Epstein-Barr virus (EBV)-transformed B-cell lines. Various combinations of exonic primers were tried and we list here the ones that resulted in successful amplifications.
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From The primers were used in the following combinations: 96F/448R; 409F/840R; 796F/I 120R; I I OOF/I 5 18R; 1448F/I 860R; 183 I F/ 1950R; 1 889/2280R; 2260F/2420R; 2370F/2640R; 2500F/3230R; 3303F/349SR. Thirty cycles of amplification were performed. The denaturation step was at 94°C for 1 minute for all combinations; the polymerization step was at 72°C for 2 minutes for all the amplifications except for the 1448/1860R, the 2370F/2640R, and 25" 3230R. which was at 72°C for 3 minutes. Annealing step was always for I minute, at 60°C for 96F/448R, at 61°C for 1448F/1860R, and at 59°C for all the other primer pairs.
PCR amplification products were cloned in the TA vector (Invitrogen, San Diego, CA) and sequenced by dideoxynucleotide chain termination method using the Sequenase kit (USB, Cleveland, OH). Exon boundaries were determined by comparing the cDNA sequence with the sequence of the various PCR products from genomic DNA of normal subjects. 
RESULTS
To understand the molecular basis of the deletion of patient CM (see below) we analyzed the exon-intron structure of the Jak3 gene. The whole gene was amplified by designing primers in the exonic sequences and trying various pairs. The successful primer pairs are listed in Materials and Methods and the gene portions amplified by each pair are shown in Fig 1. The presence of alternative transcript processing in correspondence to nucleotide 3302 has been reported in an article that also lists 15 discrepancies Juk3 gene structure. For
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with the published ~equence.'~ All these discrepancies were confirmed by us.
The gene is composed of 20 exons distributed along approximately 15 kb. All the splice junctions show the invariant GT/AG dinucleotides. Seven conserved domains (JH7 to JHl from the NH2 terminus to the COOH terminus) in Jak family members have been described, including a kinase domain (JHI) at the C-terminus and a kinase-like domain (JH2) just preceding JHl! Apart from the kinase domain, the function of the other six conserved domains is totally unknown. These domains do not appear to be coded for by specific exons, as there is very little correspondence between domains and exon boundaries. Most exons coding for domains are interrupted by introns and only the ends of JH4 and JH2 are relatively close to exon boundaries, as shown in Fig 1. The whole gene has been directly amplified from genomic DNA by amplifying overlapping DNA segments with primers designed on exon sequences. As a result of these experiments, we were able to sequence at least 40 bp of intronic sequences flanking the exon-intron boundaries, which are shown in Table 1 . This will allow the amplification of single exon with intronic primers, thus providing DNA segments that can be analyzed by rapid-mutation detection methods such a single-strand conformation polymorphism Donor splice site mutation in patient CM. We have previously shown that the patient CM Jak3 transcript had a deletion of 151 bases corresponding to nucleotides 2295 to 2445 (inclusive).' As previously described, both consanguineous parents bear the same deletion in one allele. Homozygosity for the deletion in the proband rules out the possibility that the patient is a chimera and that some of his cells bear a normal allele. In addition, neither normal transcripts at reverse transcriptase (RT)-PCR nor residual protein reactive with specific antibodies were detected in patient's lymphoid cells before transplantation (see Figs 3 and 4 in ref 9 ). although for technical reasons we could not perform PCR or immunoblot experiments on fresh monocytes (the patient underwent BMT at 4 months of age). Moreover, by mixing experiments we were able to show that as little as 4% of the normal transcript is easily detected by agarose gel staining with ethidium bromide (data not shown). Taken together, these data strongly suggest that the abnormality in patient CM is a null mutation and that there is no residual activity present in his monocytes before the BMT. Having established the whole exon-intron structure of Jak3, we were able to determine that the deletion in patient CM corresponded to the boundaries of exon 16. Amplification of the region with primers located in the flanking exons allowed us to amplify a PCR product of the same size as the normal one. This strongly suggested that the transcript abnormality was caused by a splice site mutation, with exon skipping. Sequencing of the exon 16 boundaries detected a T to C transition in the invariant GT dinucleotide of the donor splice site in two of two PCR clones (Fig 2) . The same abnormality was detected in two of five clones amplified from the mother's DNA. Mutations of this kind are known to cause exon skipping of the preceding exon. Therefore, it can be concluded that the deletion in the transcript of patient CM is due to skipping of exon 16 caused by a donor splice site mutation at the genomic level.
(SSCP). IL-8 are made also by other leukocytes (eg, NK cells), in preliminary assays we found that monocyte depletion virtually abrogated production of these mediators in response to IL-2 and LPS. Also, patient CM showed undetectable levels of CD16' NK cells, potentially a source of TNF-a and IL-8 in response to IL-2.
IL-4, which interacts with a yc receptor, induces expression and release of sIL-lra in myelomonocytic cells.'4 sILIra is also induced in monocytes by IL-13," a cytokine that shares component(s) of the receptor complex with IL-4, but not the yc chain?6m Therefore, we examined the responsiveness of Jak3-SCID monocytes to IL-4 and E-13 in terms of induction of sIL-ha. As shown in Fig 3A, PBMC from the Jak3-SCID patient CM produced normal amounts of sIL-lra in response to IL-4 and IL-13.
In an effort to extend analysis to another cytokine interacting with a yc receptor and able to activate monocytes. IL-2 was studied because this molecule has been shown to activate monocyte functions, including production of TNF and IL-8.*' PBMC from Jak3-patient CM showed normal levels of cytokine production in response to IL-2 (Fig 3B  and C) . Bacterial LPS augments expression of Jak3, although it does not cause its phosphorylation." As shown in Fig 3B and C, PBMC from the Jak3-SCID patient CM showed normal responsiveness to LPS in terms of TNF and IL-8 production. Similar results were obtained when production of the chemokine MCP-1 was measured using IL-2 or LPS as stimuli (not shown). The production of TNF was in the upper range of the normal with 13.1 (IL-2) and 11.5 ng/mL (LPS) compared with 11.5 ? 6.3 and 9.05 2 9.56 (mean % SD) for 14 normal buffy-coat donors. IL-4 elicits a complex spectrum of responses in monocytes, including induction of anti-inflammatory molecules and suppression of inflammatory cytokine production.'*-'' Therefore, it was important to investigate whether Jak3-monocytes were sensitive to IL-4-mediated suppression of function. As shown in Fig 3D, IL-4 and, by way of comparison, IL-13, inhibited LPS-induced cytokine production (TNF and IL-8) as effectively in Jak3-PBMC as in control normal cells.
IFN-y and, to a lesser degree, IL-4 and IL-13, upregulate class I1 MHC antigen expression in monocytes." IFN-y augments Jak3 expression in monocytes." As shown in Fig 4, monocytes from Jak3-SCID upregulated class I1 MHC in response to IFN-y. A similar trend was observed after expoFor personal use only. on April 13, 2017. by guest www.bloodjournal.org From sure to IL-4 and IL-13, although levels of induction were low in patient CM as well as in control pediatric patients (not shown). Finally, PMN from Jak3-SCID showed normal migration to fMLP and IL-8 and oxidative burst to phorbol ester (not shown).
DISCUSSION
The present study was aimed at investigating the structural basis and immunobiology of autosomal SCID associated with lack of Jak3 kinase. Structurally, we found that the Jak3 gene is organized into 20 exons distributed over more than 15 kb, with little correspondence between exon boundaries and the structural domains that are conserved among the Jak family members: To our knowledge, the exon-intron structure of other Jak family members has not yet been elucidated, and it is not known whether intron positions are conserved also in the other Janus kinases or whether intron insertions occurred after the divergence of these genes. We report here that it is possible to amplify almost entirely the Jak3 locus by PCR with a set of primers that allow the determination of the genomic structure of the gene and the study of exon-intron junctions. In this way, we were able to determine that the deletion in the transcript of patient CM is caused by a T to C transition in the invariant GT dinucleotide at the donor splice site of exon 16. This mutation apparently causes the skipping of the preceding exon in patient CM, a phenomenon frequently described in similar cases" (and references therein).
The definition of the whole exon-intron structure and of a set of primers able to amplify most of the locus is the first step for the analysis at the DNA level of all the B+ T-SCID patients with normal yc chain. The need to proceed to BMT early in life results in the availability of genomic DNA from nonhematopoietic tissues, the only source to search for JAK3 mutation after BMT. In addition, JAK3 expression is restricted to subsets of blood cells; therefore, prenatal diagnosis has to be performed at the DNA level. Taking advantage of the intronic sequences around the splice sites reported in this article, we are currently devising SSCP analysis for mutation screening of JAK3-deficient patients, which appear to be more frequent than previously supposed (Villa A., Notarangelo L., unpublished results, March 1996).
Jak3 deficiency is associated with autosomal SCID characterized by lack of T and NK cell development.' Mononuclear phagocytes express Jak3 and this signal transducing molecule is functionally coupled to the monocyte IL-2 and IL-4 receptors that share the yc IFN-y and LPS, two prototypic macrophage activation signals, augment Jak3 expression in monocytes." Therefore, it was important to investigate monocyte function in Jak3-SCID patients.
Autosomal J&3-SCID patient CM showed normal numbers of circulating monocytes. IL-4 induced normal levels of sIL-Ira production in CM monocytes. Moreover, IL-4 also effectively inhibited the capacity of CM monocytes to produce cytokines (IL-8 and TNF) in response to LPS. Thus, the stimulatory and inhibitory actions of IL-4 on monocytes are unaffected by lack of Jak3 kinase. IL-4 and IL-13 show considerable similarities in their biologic actions, including those on myelomonocytic cells, and share component(s) in the receptor c~mplexes.~'.~~ IL-13 does not act via a yc receptor and does not activate Jak3.26-30 Both IL-4 and IL-13 induce tyrosine phosphorylation of 4PS and Jak-1, and the IL-4 receptor interacts with Jak-1 .27.14 It is tempting to speculate that this signaling pathway shared by IL-4 and IL-13 may account for the responsiveness of Jak3-SCID monocytes to
The p and yc chains of the IL-2 receptor bind and activate distinct nonreceptor tyrosine kinase^.^ The 0 chain activates Jak-1, converging on STAT5 with yc chain-activated Jak3, as well as the src family kinases syk and lck, involved in bcl-2, c-fos, and c-myc induction. Activation of these alternative signaling pathways centered on the receptor p chain may account for normal IL-2 responsiveness of Jak3-SCID monocytes.
Thus, the results reported here show that the Jak3 kinase, expressed and activated in myelomonocytic cells, is dispensable for monocyte differentiation and responsiveness to IL-2 and IL-4, which interact with yc receptors, as well as to IFN-y, IL-13, and LPS. One can infer that regulation of mononuclear phagocytes occurs via other receptor-coupled tyrosine kinases (eg, Jak-l or lck). It remains to be established whether this observation entirely reflects normal monocyte physiology or, at least in part, adaptation during ontogeny in the absence of Jak3.
IL-4.
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